510(k) K192777
K192777 is an FDA 510(k) premarket notification submitted by Siemens Healthcare Diagnostics, Inc. for the device "ADVIA Centaur CA 15-3 assay". The FDA issued a decision of Substantially Equivalent on November 22, 2019. The device falls under product code MOI (System, Test, Immunological, Antigen, Tumor), a Class II device regulated under 21 CFR 866.6010. Siemens Healthcare Diagnostics, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- November 22, 2019
- Date Received
- September 30, 2019
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Test, Immunological, Antigen, Tumor
- Device Class
- Class II
- Regulation Number
- 866.6010
- Review Panel
- IM
- Submission Type